JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kimura, T.
Right arrow Articles by Satoh, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kimura, T.
Right arrow Articles by Satoh, S.

Inhibitory effect of quinacrine on myocardial reactive hyperemia in the dog

T Kimura and S Satoh

We investigated the effect of quinacrine, a phospholipase A2 inhibitor, on myocardial reactive hyperemic response after 5-, 10- and 20-sec coronary occlusions and adenosine-induced coronary vasodilatation in perfused dog hearts in situ. Continuous infusions of quinacrine (30-300 micrograms/min) into the left coronary artery significantly reduced both reactive hyperemic response and increase in coronary blood flow produced by intracoronary injections of adenosine (1-30 micrograms) without significant effect on basal coronary blood flow, perfusion pressure and heart rate. Neither acetylcholine- nor verapamil-induced increases in coronary blood flow were modified by quinacrine. The reactive hyperemic response and the vasodilatory effect of adenosine were both reduced by intracoronary infusions of theophylline (100-1000 micrograms/min). The inhibitory effect of theophylline on the reactive hyperemic response was less prominent than that of quinacrine, whereas the vasodilatory effect of adenosine was reduced to the same extent by both drugs. Intracoronary infusions of indomethacin (a cyclooxygenase inhibitor), phenidone (an inhibitor of both cyclooxygenase and lipoxygenase) and nordihydroguaiaretic acid (a lipoxygenase inhibitor) did not affect the reactive hyperemic response. The present results support the hypothesis that adenosine may be a mediator of myocardial reactive hyperemia and suggest that other factors, possibly phospholipase products, may also contribute to this phenomenon. We were unable to define the mechanism involved; however, it can be excluded that cyclooxygenase and lipoxygenase products of arachidonic acid contribute to myocardial reactive hyperemia.

Volume 232, Issue 1, pp. 269-274, 01/01/1985
Copyright © 1985 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
P. Pagliaro, N. Paolocci, T. Isoda, W. F Saavedra, G. Sunagawa, and D. A Kass
Reversal of glibenclamide-induced coronary vasoconstriction by enhanced perfusion pulsatility: possible role for nitric oxide
Cardiovasc Res, March 1, 2000; 45(4): 1001 - 1009.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
K. A. Engelke, J. R. Halliwill, D. N. Proctor, N. M. Dietz, and M. J. Joyner
Contribution of nitric oxide and prostaglandins to reactive hyperemia in the human forearm
J Appl Physiol, October 1, 1996; 81(4): 1807 - 1814.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1985 by the American Society for Pharmacology and Experimental Therapeutics.